Skip to main content

Innovex Announces Third Quarter 2025 Results

Innovex International, Inc. (NYSE: INVX) (“Innovex,” the “Company” or “we”) today announced financial and operating results for the third quarter of 2025.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251103731415/en/

Innovex Announces Third Quarter 2025 Results. Revenue of $240 million, up 7% quarter over quarter.

Innovex Announces Third Quarter 2025 Results. Revenue of $240 million, up 7% quarter over quarter.

Third Quarter Highlights

  • Revenue of $240 million, up 7% quarter over quarter
  • Net Income of $39 million, net income margin of 16%
  • Adjusted EBITDA1 of $44 million and Adjusted EBITDA Margin1 of 18%
  • Net Cash Provided by Operating Activities of $48 million
  • Free Cash Flow1 of $37 million
  • Income from Operations of $134 million (twelve months ended September 30, 2025)
  • Return on Capital Employed1 of 13%
  • Closed on sale of legacy Dril-Quip Eldridge Facility for $90.0 million
  • Signed agreement to become exclusive subsea wellhead provider for OneSubsea

(1)

Adjusted EBITDA, Adjusted EBITDA Margin, Free Cash Flow and Return on Capital Employed (“ROCE”) are non-GAAP measures. Reconciliations of Adjusted EBITDA to net income, Free Cash Flow to net cash provided by operating activities and ROCE to income from operations, the most directly comparable financial measures presented in accordance with GAAP, are outlined in the reconciliation tables accompanying this release.

Adam Anderson, CEO commented, “In the third quarter the company made significant progress on our key strategic initiatives, which should continue to drive market share gains near term, as well as a step change in margins over the mid-term. We continued to increase our market share in the U.S. Land market after successfully integrating Citadel and outperforming relatively flat US land activity. During the quarter we made significant progress on the transformation of the subsea product line. The closing of the sale of our Eldridge facility is a foundational element of our plan to drive a step change in subsea margins, although facility relocation costs did weigh on margins in the current quarter. On-time delivery for our subsea business continued to improve- achieving 76% in the quarter- with line of sight to legacy Innovex's historical levels in the back half of next year. We expect to substantially exit the Eldrige facility by year end, which will enable further improvement in our operating results in 2026. This operational momentum is driving commercial success- as evidenced by our new partnership with OneSubsea. As the exclusive wellhead provider on bundled subsea packages, Innovex expects to meaningfully grow our already strong position in the subsea wellhead market. These achievements highlight the momentum we are building across the Innovex platform as we continue to execute on our long-term goals of growth, operational excellence, and margin expansion.”

Kendal Reed, CFO continued, “Our capital-light business model and disciplined cost control allowed us to maintain strong free cash flow and healthy margins despite ongoing macro uncertainty. Closing the Eldridge facility sale generated $87 million in net proceeds1 ,further strengthening our net cash position and giving us significant flexibility to pursue high-return opportunities. Our balance sheet strength provides us with optionality as we evaluate a robust M&A pipeline of capital-efficient businesses that align with our stringent requirements. We have remaining authorization to repurchase up to approximately $90.7 million of our shares and continue to evaluate share repurchases against a robust M&A pipeline of capital-efficient businesses that align with our ‘big impact, small ticket’ product strategy.”

1 Net proceeds value is defined as final sale price less leaseback and real estate tax prorations, broker fees, and title/escrow fees.

Financial Summary

 

 

Three months ended

(in thousands)

 

September 30,

2025

 

June 30,

2025

 

September 30,

2024

Revenue

 

$

240,000

 

 

$

224,234

 

 

$

151,817

 

Net Income

 

 

39,228

 

 

 

15,345

 

 

 

82,586

 

Net Income (Loss) % Revenue

 

 

16

%

 

 

7

%

 

 

54

%

Adjusted EBITDA (1)

 

 

43,613

 

 

 

46,642

 

 

 

27,411

 

Adjusted EBITDA Margin (1)

 

 

18

%

 

 

21

%

 

 

18

%

Net cash provided by operating activities

 

 

48,374

 

 

 

59,210

 

 

 

21,722

 

Free Cash Flow (1)

 

 

36,522

 

 

 

51,913

 

 

 

20,051

 

Income from operations

 

 

62,284

 

 

 

22,695

 

 

 

(13,218

)

 

 

Twelve Months Ended

 

 

September 30,

2025

 

December 31,

2024

 

September 30,

2024

ROCE (1)

 

 

13

%

 

 

12

%

 

 

9

%

 
(1) Adjusted EBITDA, Adjusted EBITDA Margin, Free Cash Flow and Return on Capital Employed (“ROCE”) are non-GAAP financial measures. See definition of these measures and the reconciliation of GAAP to non-GAAP financial measures in the Supplemental Information tables below.

Operational & Financial Results

Kendal Reed, CFO continued, “We continue to manage supply chains and contracts to minimize any exposure to tariffs. The increase in our SG&A and capex sequentially related primarily to incremental costs associated with the exit of the Eldridge facility and the inclusion of a full quarter of Citadel results. We expect costs related to the Eldridge facility exit to continue into Q4 and expect to be substantially moved out of this legacy facility by the end of the year. As discussed previously, we believe exiting this facility unlocks the first major step in our aspirations of mid 20s EBITDA Margins. Importantly, the near-term costs are far outweighed by the cash proceeds from the sale and the potential for higher margins that is unlocked by a streamlined manufacturing footprint.”

Adam Anderson, CEO concluded, “I am pleased with the market share gains in US land, as well as an improving outlook for our international business. Our differentiated product suite continues to drive value for our customers. In Abu Dhabi, for instance, multiple Innovex technologies were instrumental in drilling a 54,000 foot well - a record for the region. Despite soft activity in Saudi Arabia during the quarter, we have made tangible progress in growing our market position, which we anticipate to be evident in our results by early 2026. We also made significant subsea products deliveries into the Middle East during the quarter. We executed well against our mid-cycle playbook, as we continued growing market share organically, generating cash, and evaluating exciting inorganic opportunities for further, high return growth. We look forward to sharing more in the coming quarters.”

Balance Sheet, Debt, Cash Flow & Other

Net cash provided by operating activities was $48 million and capital expenditures were $12 million (approximately 5% of revenue) for the third quarter of 2025. The incremental increase in capex was primarily related to short-term facility consolidation efforts.

Innovex generated free cash flow of $37 million during the third quarter of 2025 and ended the quarter with $163 million of cash and cash equivalents and $26 million of total debt. Innovex ended the quarter with $132.8 million of availability under its revolving credit facility.

Innovex maintains conservative levels of leverage and ample liquidity to maximize strategic flexibility and to capitalize on M&A opportunities that meet our stringent quantitative and qualitative characteristics.

Return on Capital Employed (“ROCE”)

Innovex’s efficient capital allocation and capital-light business model enable the Company to generate strong returns on our invested capital. Income from operations for the twelve months ended September 30, 2025 was $134 million. Return on Capital Employed (“ROCE”) for the twelve months ended September 30, 2025 was 13%. We remain focused on capital efficiency, which we believe is a key driver of sustainable value creation for our stockholders.

Q4 2025 Guidance

Looking to the fourth quarter of 2025, Innovex expects to generate $235 - $245 million in total revenue. Innovex expects to generate Adjusted EBITDA of $42 - $47 million in the fourth quarter of 2025.

Conference Call Details

Management will host a conference call and a webcast to discuss the financial results on November 4, 2025, at 10:00 a.m. Eastern Daylight Time / 9:00 a.m. Central Daylight Time. The presentation is open to all interested parties and may include forward-looking information. To access the call, please dial in approximately ten minutes before the start of the call.

Date / Time: November 4, 2025 - 9:00 AM Central Time

Webcast: https://events.q4inc.com/attendee/627013927

U.S. Toll-Free Dial-In: (800) 715-9871

International Dial-In: +1 (646) 307-1963

Conference ID: 6263613

For those unable to participate in the live call, an audio replay will be available following the call through midnight Tuesday, November 11, 2025. To access the replay, please call (800) 770-2030 or +1 (609) 800-9909 (International) and enter playback ID 6263613 followed by the # key. A replay of the webcast will also be archived shortly after the call and can be accessed on the Company's website.

About Innovex International, Inc.

Innovex International, Inc (NYSE: INVX) is a Houston-based company established in 2024 following the merger of Dril-Quip, Inc and Innovex Downhole Solutions, Inc.

Our comprehensive portfolio extends throughout the lifecycle of the well, and innovative product integration ensures seamless transitions from one well phase to the next, driving efficiency, lowering cost, and reducing the rig site service footprint for the customer.

With locations throughout North America, Latin America, Europe, the Middle East and Asia, no matter where you need us, our team is readily available with technical expertise, conventional and innovative technologies, and ever-present customer service.

Forward-Looking Statements

Certain statements contained in this press release and oral statements made regarding the matters addressed in this release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of Innovex’s control, that could cause actual results to differ materially from the results discussed in the forward-looking statements.

Forward-looking statements can be identified by the use of forward-looking terminology including “may,” “believe,” “expect,” “intend,” “anticipate,” “plan,” “should,” “estimate,” “continue,” “potential,” “will,” “hope” or other similar words and include the Company’s expectation of future performance contained herein. These statements discuss future expectations, contain projections of results of operations or of financial condition, or state other “forward-looking” information, including without limitation statements regarding the expected benefits of the sale of the Eldridge facility. You are cautioned not to place undue reliance on any forward-looking statements, which can be affected by assumptions used or by risks or uncertainties. Consequently, no forward-looking statements can be guaranteed. When considering these forward-looking statements, you should keep in mind the risks related to the Company’s merger and acquisition activities, including the ultimate outcome and results of integrating operations, the effects of the Company’s merger and acquisition activities (including the Company’s future financial condition, results of operations, strategy and plans), potential adverse reactions or changes to business relationships resulting from the completion of mergers and acquisitions, expected benefits from mergers and acquisition and the ability of the Company to realize those benefits, the significant costs required to integrate operations, whether merger or acquisition-related litigation will occur and, if so, the results of any litigation, settlements and investigations, operating hazards, natural disasters, weather-related delays, casualty losses and other matters beyond our control; acts of terrorism, war or political or civil unrest in the United States or elsewhere; loss or corruption of our information or a cyberattack on our computer systems; the risks related to economic conditions and other factors noted in the Company’s Annual Report on Form 10-K, any Quarterly Reports on Form 10-Q and the other documents that the Company files with the Securities and Exchange Commission. The risk factors and other factors noted therein could cause actual results to differ materially from those contained in any forward-looking statement. Innovex disclaims any duty to update and does not intend to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this press release, except as may be required by law.

Innovex International, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Income

(Unaudited)

 

 

 

Three months ended

(in thousands, except share and per share amounts)

 

September 30,

2025

 

June 30,

2025

 

September 30,

2024

Revenues

 

$

240,000

 

 

$

224,234

 

 

$

151,817

 

Cost of revenues

 

 

164,057

 

 

 

152,515

 

 

 

99,138

 

Selling, general and administrative expenses

 

 

35,574

 

 

 

28,835

 

 

 

37,984

 

Gain on sale of assets

 

 

(40,918

)

 

 

(419

)

 

 

(169

)

Depreciation and amortization

 

 

15,362

 

 

 

14,974

 

 

 

7,786

 

Impairment of long-lived assets

 

 

 

 

 

503

 

 

 

 

Acquisition and integration costs

 

 

3,641

 

 

 

5,131

 

 

 

20,296

 

Income from operations

 

$

62,284

 

 

$

22,695

 

 

$

(13,218

)

Interest expense

 

 

677

 

 

 

551

 

 

 

729

 

Other expense (income), net

 

 

303

 

 

 

(92

)

 

 

(269

)

Equity method earnings

 

 

 

 

 

 

 

 

(1,018

)

Bargain purchase loss/(gain)

 

 

3,342

 

 

 

 

 

 

(92,659

)

Income before income taxes

 

$

57,962

 

 

$

22,236

 

 

$

79,999

 

Income tax expense/(benefit), net

 

 

18,734

 

 

 

6,891

 

 

 

(2,587

)

Net income

 

$

39,228

 

 

$

15,345

 

 

$

82,586

 

Foreign currency translation adjustment

 

 

1,314

 

 

 

6,728

 

 

 

2,457

 

Comprehensive income

 

$

40,542

 

 

$

22,073

 

 

$

85,043

 

Earnings per common share

 

 

 

 

 

 

 

 

 

Basic

 

$

0.57

 

 

$

0.22

 

 

$

2.03

 

Diluted

 

$

0.57

 

 

$

0.22

 

 

$

1.99

 

Weighted average common shares outstanding

 

 

 

 

 

 

 

 

 

Basic

 

 

68,814,125

 

 

 

68,943,387

 

 

 

40,728,902

 

Diluted

 

 

69,265,300

 

 

 

69,147,457

 

 

 

41,530,978

 

Innovex International, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

 

(in thousands, except share and par value amounts)

 

September 30,

2025

 

June 30,

2025

 

September 30,

2024

Assets

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

163,374

 

 

$

68,781

 

 

$

99,895

 

Trade receivable, net

 

 

220,408

 

 

 

220,966

 

 

 

225,067

 

Inventories, net

 

 

275,197

 

 

 

278,495

 

 

 

297,519

 

Other current assets

 

 

51,373

 

 

 

101,863

 

 

 

54,851

 

Total current assets

 

 

710,352

 

 

 

670,105

 

 

 

677,332

 

Noncurrent assets

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

158,685

 

 

 

150,670

 

 

 

182,230

 

Equity method investment

 

 

 

 

 

 

 

 

19,923

 

Goodwill and net intangibles

 

 

215,863

 

 

 

218,864

 

 

 

59,719

 

Right of use leases - operating, net

 

 

54,745

 

 

 

56,512

 

 

 

47,352

 

Deferred tax asset, net

 

 

104,132

 

 

 

122,129

 

 

 

138,523

 

Other long-term assets

 

 

10,133

 

 

 

8,801

 

 

 

7,704

 

Total noncurrent assets

 

 

543,558

 

 

 

556,976

 

 

 

455,451

 

Total assets

 

$

1,253,910

 

 

$

1,227,081

 

 

$

1,132,783

 

Liabilities and stockholders’ equity

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

66,633

 

 

$

65,321

 

 

$

83,613

 

Accrued expenses

 

 

45,680

 

 

 

48,556

 

 

 

55,884

 

Operating lease liabilities

 

 

12,785

 

 

 

12,341

 

 

 

9,093

 

Contract liabilities

 

 

10,286

 

 

 

6,911

 

 

 

14,090

 

Other current liabilities

 

 

7,010

 

 

 

6,678

 

 

 

1,430

 

Current portion of long-term debt and finance lease obligations

 

 

6,316

 

 

 

5,938

 

 

 

10,695

 

Total current liabilities

 

 

148,710

 

 

 

145,745

 

 

 

174,805

 

Noncurrent liabilities

 

 

 

 

 

 

 

 

 

Long-term debt and finance lease obligations

 

 

20,090

 

 

 

34,780

 

 

 

12,351

 

Operating lease liabilities

 

 

43,287

 

 

 

45,634

 

 

 

39,314

 

Other long-term liabilities

 

 

2,869

 

 

 

5,369

 

 

 

1,962

 

Total noncurrent liabilities

 

 

66,246

 

 

 

85,783

 

 

 

53,627

 

Total Liabilities

 

$

214,956

 

 

$

231,528

 

 

$

228,432

 

Total stockholders’ equity

 

$

1,038,954

 

 

$

995,553

 

 

$

904,351

 

Total liabilities and stockholders’ equity

 

$

1,253,910

 

 

$

1,227,081

 

 

$

1,132,783

 

Innovex International, Inc.

Condensed Consolidated Statement of Cash Flows

(Unaudited)

 

 

 

Three months ended

(in thousands)

 

September 30,

2025

 

June 30,

2025

 

September 30,

2024

Cash flows from operating activities

 

 

 

 

 

 

 

 

 

Net Income

 

$

39,228

 

 

$

15,345

 

 

$

82,586

 

Adjustments to reconcile net income to net cash provided by operating activities

 

 

1,848

 

 

 

29,375

 

 

 

(71,311

)

Changes in operating assets and liabilities, net of amounts related to acquisitions

 

 

7,298

 

 

 

14,490

 

 

 

10,447

 

Net cash provided by operating activities

 

$

48,374

 

 

$

59,210

 

 

$

21,722

 

Cash flows used in investing activities

 

 

 

 

 

 

 

 

 

Payments on acquisitions, net of cash acquired

 

 

(500

)

 

 

(63,256

)

 

 

 

Capital expenditures

 

 

(11,852

)

 

 

(7,297

)

 

 

(1,671

)

Proceeds from sale of property and equipment

 

 

89,907

 

 

 

7,681

 

 

 

1,074

 

Cash acquired in stock based business combination

 

 

 

 

 

 

 

 

154,312

 

Net cash used in investing activities

 

$

77,555

 

 

$

(62,872

)

 

$

153,715

 

Cash flows provided by financing activities

 

 

 

 

 

 

 

 

 

Net Borrowings (Repayments) on line of credit

 

 

(29,000

)

 

 

13,400

 

 

 

 

Net Repayments on term loan

 

 

 

 

 

 

 

 

(2,533

)

Payments on Finance Leases

 

 

(1,793

)

 

 

(1,869

)

 

 

(1,386

)

Dividend payment

 

 

 

 

 

 

 

 

(74,983

)

Other Financing

 

 

(384

)

 

 

(9,089

)

 

 

(6,388

)

Net cash provided by (used in) financing activities

 

$

(31,177

)

 

$

2,442

 

 

$

(85,290

)

Effect of exchange rate changes on cash and cash equivalents

 

 

(159

)

 

 

1,885

 

 

 

(608

)

Net change in cash and cash equivalents

 

$

94,593

 

 

$

665

 

 

$

89,539

 

Non-GAAP Measures

Adjusted EBITDA and Adjusted EBITDA Margin

We define Adjusted EBITDA (a non-GAAP measure) as net income before interest expense, income tax expense, depreciation and amortization, (gain)/loss on sale of assets and other expense, net, further adjusted to exclude certain items which we believe are not reflective of our ongoing performance or which are non-cash in nature. Management uses Adjusted EBITDA to assess the profitability of our business operations and to compare our operating performance to our competitors without regard to the impact of financing methods and capital structure and excluding costs that management believes do not reflect our ongoing operating performance. We track Adjusted EBITDA on an absolute dollar basis and as a percentage of revenue, which we refer to as Adjusted EBITDA Margin.

Free Cash Flow

We also utilize Free Cash Flow (a non-GAAP measure) to evaluate the cash generated by our operations and results of operations. We define Free Cash Flow as net cash provided by operating activities less capital expenditures, as presented in our Consolidated Statements of Cash Flows. Management believes Free Cash Flow is useful because it demonstrates the cash that was available in the period that was in excess of our needs to fund our capital expenditures. We track Free Cash Flow both on an absolute dollar basis and as a percentage of revenue. Free Cash Flow does not represent our residual cash flow available for discretionary expenditures, as we have non-discretionary expenditures, including, but not limited to, principal payments required under the terms of our credit facility, which are not deducted in calculating Free Cash Flow.

Return on Capital Employed (ROCE)

We utilize Return on Capital Employed ("ROCE") (a non-GAAP measure) to assess the effectiveness of our capital allocation over time and to compare our capital efficiency to our competitors. We define ROCE as Income from Operations, before acquisition and integration costs and after tax (resulting in Adjusted Income from Operations, after tax) divided by average capital employed. Capital employed is defined as the combined values of debt and stockholders’ equity.

Adjusted EBITDA, Adjusted EBITDA Margin, Free Cash Flow and ROCE do not represent and should not be considered alternatives to, or more meaningful than, net income and net cash provided by operating activities, or any other measure of financial performance presented in accordance with GAAP as measures of our financial performance. Our computation of Adjusted EBITDA, Free Cash Flow and ROCE may differ from computations of similarly titled measures of other companies. For a reconciliation of these non-GAAP measures to the most directly comparable GAAP measure, see tables below.

Management has provided outlook regarding Adjusted EBITDA, which is a non-GAAP financial measure and excludes certain charges. A reconciliation of this non-GAAP financial measure to the corresponding GAAP financial measure has not been provided because guidance for the various reconciling items is not provided. The Company is unable to provide guidance for these reconciling items because they cannot determine their probable significance, as certain items are outside of the Company's control and cannot be reasonably predicted since these items could vary significantly from period to period. Accordingly, reconciliations to the corresponding GAAP financial measures are not available without unreasonable effort.

Innovex International, Inc.

Reconciliation of Net Income to Adjusted EBITDA

(Unaudited)

 

 

 

Three months ended

(in thousands)

 

September 30,

2025

 

June 30,

2025

 

September 30,

2024

Revenue

 

$

240,000

 

 

$

224,234

 

 

$

151,817

 

Net Income

 

 

39,228

 

 

 

15,345

 

 

 

82,586

 

Interest expense

 

 

677

 

 

 

551

 

 

 

729

 

Income tax expense/(benefit), net

 

 

18,734

 

 

 

6,891

 

 

 

(2,587

)

Depreciation and amortization

 

 

15,362

 

 

 

14,974

 

 

 

7,786

 

EBITDA

 

$

74,001

 

 

$

37,761

 

 

$

88,514

 

Other non-operating income, net (1)

 

 

303

 

 

 

(92

)

 

 

(269

)

(Gain)/Loss on sale of assets

 

 

(40,918

)

 

 

(419

)

 

 

(169

)

Impairment of long-lived assets

 

 

 

 

 

503

 

 

 

 

Acquisition and integration costs (2)

 

 

3,641

 

 

 

5,131

 

 

 

20,296

 

Equity Method Adjustment (3)

 

 

 

 

 

 

 

 

790

 

Bargain purchase loss/(gain)

 

 

3,342

 

 

 

 

 

 

(92,659

)

Stock based compensation

 

 

3,244

 

 

 

3,758

 

 

 

10,908

 

Adjusted EBITDA

 

$

43,613

 

 

$

46,642

 

 

$

27,411

 

Net Income (Loss) % Revenue

 

 

16

%

 

 

7

%

 

 

54

%

Adjusted EBITDA Margin

 

 

18

%

 

 

21

%

 

 

18

%

(1) Primarily represents foreign currency exchange gain/loss, gain/loss on lease terminations, and other non-operating items.
(2) Consists of legal, accounting, advisory fees, and other integration costs associated with acquisitions, primarily related to Dril-Quip, DWS, SCF and Citadel. These costs are one-time in nature and represent expenses that we do not view as normal operating expenses necessary to operate our business.
(3) Reflects the elimination of our percentage of interest expense, depreciation, amortization and other non-recurring expenses included within equity method earnings pertaining to our unconsolidated investment in DWS.

Innovex International, Inc.

Reconciliation of Income from Operations to ROCE

(Unaudited)

 

 

 

Twelve Months Ended

(in thousands)

 

September 30,

2025

 

December 31,

2024

 

September 30,

2024

Income from operations

 

$

133,741

 

 

$

49,075

 

 

$

45,465

 

Plus: Acquisition and integration costs

 

 

20,868

 

 

 

33,300

 

 

 

25,834

 

Less: Income tax expense

 

 

(27,857

)

 

 

(2,487

)

 

 

(11,901

)

Adjusted income from operations, after tax

 

$

126,752

 

 

$

79,888

 

 

$

59,398

 

Beginning debt

 

 

23,046

 

 

 

50,390

 

 

 

69,997

 

Beginning equity

 

 

904,351

 

 

 

328,921

 

 

 

307,946

 

Ending debt

 

 

26,406

 

 

 

35,368

 

 

 

23,046

 

Ending equity

 

 

1,038,954

 

 

 

958,156

 

 

 

904,351

 

Average capital employed

 

$

996,379

 

 

$

686,418

 

 

$

652,670

 

ROCE

 

 

13

%

 

 

12

%

 

 

9

%

Innovex International, Inc.

Reconciliation of Net Cash from Operations to Free Cash Flow

(Unaudited)

 

 

 

Three months ended

(in thousands)

 

September 30,

2025

 

June 30,

2025

 

September 30,

2024

Net cash provided by operating activities

 

$

48,374

 

 

$

59,210

 

 

$

21,722

 

Capital expenditures

 

 

(11,852

)

 

 

(7,297

)

 

 

(1,671

)

Free Cash Flow

 

$

36,522

 

 

$

51,913

 

 

$

20,051

 

Innovex International, Inc.

Geographic Revenue Details

(Unaudited)

 

 

 

Three months ended

(in thousands)

 

September 30,

2025

 

June 30,

2025

 

September 30,

2024

North America Onshore ("NAM")

 

 

 

 

 

 

 

 

 

Product revenues

 

$

86,597

 

 

$

77,368

 

 

$

79,668

 

Rental revenues

 

 

28,114

 

 

 

26,698

 

 

 

5,228

 

Service revenues

 

 

17,218

 

 

 

15,901

 

 

 

13,411

 

Revenue - North America Onshore

 

 

131,929

 

 

 

119,967

 

 

 

98,307

 

International & Offshore

 

 

 

 

 

 

 

 

 

Product revenues

 

 

79,205

 

 

 

72,081

 

 

 

46,975

 

Rental revenues

 

 

14,274

 

 

 

17,305

 

 

 

4,172

 

Service revenues

 

 

14,592

 

 

 

14,881

 

 

 

2,363

 

Revenue - International & Offshore

 

 

108,071

 

 

 

104,267

 

 

 

53,510

 

Total Revenue

 

$

240,000

 

 

$

224,234

 

 

$

151,817

 

 

"These achievements highlight the momentum we are building across the Innovex platform as we continue to execute on our long-term goals of growth, operational excellence, and margin expansion.” Adam Anderson, President & CEO

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  254.00
+9.78 (4.00%)
AAPL  269.05
-1.32 (-0.49%)
AMD  259.65
+3.53 (1.38%)
BAC  53.56
+0.11 (0.21%)
GOOG  284.12
+2.30 (0.82%)
META  637.71
-10.64 (-1.64%)
MSFT  517.03
-0.78 (-0.15%)
NVDA  206.88
+4.39 (2.17%)
ORCL  257.85
-4.76 (-1.81%)
TSLA  468.37
+11.81 (2.59%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.